TetraLogic Pharmaceuticals Appoints Dr. Andrew Pecora to Its Board of Directors.
MALVERN, Pa. -- TetraLogic Pharmaceuticals, a privately held company privately held company
A firm whose shares are held within a relatively small circle of owners and are not traded publicly. specializing in the discovery and development of oncology therapeutics, announced today that, effective immediately, Dr. Andrew Pecora, FACP FACP Fellow of the American College of Physicians.
1. Fellow of the American College of Physicians
2. Fellow of the American College of Prosthodontists , has joined the Company's Board of Directors, bringing the Board to seven members.
John M. Gill, President and Chief Executive Officer of TetraLogic Pharmaceuticals, stated, "We are delighted to welcome Dr. Pecora to our Board. He brings to our organization a wealth of expertise in the field of hematology-oncology and cancer research, including clinical trial design, and is a pioneer in the use of Granulocyte granulocyte /gran·u·lo·cyte/ (gran´u-lo-sit?) granular leukocyte.granulocyt´ic
band-form granulocyte band cell.
n. Cell Stimulating Factor (GCSF GCSF Granulocyte Cell Stimulating Factor
GCSF Gulf, Colorado, and Santa Fe Railway Company (also abbreviated GC&SF) ) for the supportive care of cancer patients. Additionally, under his leadership, the Hackensack University Cancer Center, where he is presently Chairman and Executive Administrative Director, has become one of the top cancer centers in the United States. As Founder of two life sciences companies, Dr. Pecora also brings welcome experience in business development. We look forward to numerous contributions by Dr. Pecora as TetraLogic Pharmaceuticals moves from the pre-clinical to clinical stages of product development, and beyond."
Dr. Pecora is currently in private practice in Hackensack, NJ. In addition, he has spent the last 18 years in various capacities at Hackensack University Medical Center Hackensack University Medical Center (HUMC) is a 781-bed non-profit, research and teaching hospital located just seven miles west of New York City, in Hackensack, New Jersey, providing tertiary and healthcare needs for northern New Jersey and the New York metropolitan area. in Hackensack, NJ, currently serving as Chairman and Executive Administrative Director of The Cancer Center, Senior Scientist at the Institute for Biomedical Research, and Attending Physician of Internal Medicine, Member, Section of Hematology-Oncology. During his tenure at Hackensack University Medical Center, Dr. Pecora has also held the roles of Chairman and Director of The Cancer Center; Director, Hematology and Medical Oncology; Chief, Adult Blood and Marrow Stem Cell Transplant Service; and Medical Director, Stem Cell Collection and Storage Service, among others.
Among his numerous other professional positions, Dr. Pecora is co-Founder and co-managing partner of Northern New Jersey Cancer Associates. He is also founder and Chairman of Amorcyte, Inc., a privately funded biotechnology company developing cell therapy products to treat cardiovascular disease, and Co-founder, Chairman and Chief Executive Officer of Progenitor Cell Therapy, LLC (Logical Link Control) See "LANs" under data link protocol.
LLC - Logical Link Control , a client-based cell therapy services company supporting the development and commercialization of cellular therapies. Dr. Pecora also currently serves as Editor of the American Society of Blood and Marrow Transplantation e-News; a Member of the Medical Advisory Board of The Bone Marrow Foundation; and Member, New Jersey Working Group to Improve Outcomes in Cancer Patients.
Dr. Pecora has authored or co-authored numerous articles, abstracts, books, chapters and monographs and is a frequent lecturer in the field of cancer. He received his Bachelor of Science Noun 1. Bachelor of Science - a bachelor's degree in science
bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies degree in Biology from Seton Hall University Seton Hall University is a private Roman Catholic university located 14 miles from Manhattan in historic South Orange, New Jersey. Founded in 1856 by Archbishop James Roosevelt Bayley, Seton Hall is the oldest diocesan university in the United States. and his Medical Degree from the University of Medicine and Dentistry of New Jersey The University of Medicine and Dentistry of New Jersey is the state-run health sciences institution of New Jersey and comprises eight distinct academic units: the New Jersey Medical School, the New Jersey Dental School, the Graduate School of Biomedical Sciences, the School of . He completed both his postdoctoral internship in internal medicine as well as his residency in the Department of Internal Medicine at The New York Hospital, located in New York, NY, and completed a fellowship in hematology-oncology at Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New , also in New York. He is licensed to practice in both New Jersey and New York.
About TetraLogic Pharmaceuticals
TetraLogic Pharmaceuticals is a privately held company focused on discovering and developing new oncology drugs. Its lead program, IAP (Internet Access Provider) See ISP.
IAP - Internet Access Provider antagonists, are in preclinical development and are slated to enter clinical trials during the second half of 2007. Other apoptosis related drug discovery programs are at an earlier stage of development. To date, TetraLogic has raised a total of $44 million through private financings. The Company's investors include Amgen Ventures, HealthCare Ventures, Kammerer Associates, Latterell Venture Partners, PA Early Stage Partners, Quaker BioVentures and the Vertical Group. For additional information, please refer to the Company's website at www.tetralogicpharma.com.